• Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study

  NCT03582800

  RecruitingInterventionalPhase 2Updated Jul 20, 2026
• Intralesional Injection of STS in Treatment of Calcinosis

  NCT06672822

  RecruitingInterventionalPhase 2Updated May 5, 2026
• A Pilot Study to Evaluate Topical Sodium Thiosulfate Therapy for Calcinosis Cutis

  NCT01918904

  WithdrawnInterventionalPhase 2Updated Nov 17, 2016
• Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult Dermatomyositis

  NCT03267277

  CompletedInterventionalPhase 2Phase 3Updated Nov 26, 2024
• Efficacy of Intralesional Sodium Thiosulfate Versus Intralesional Saline for Dystrophic and Idiopathic Calcinosis Cutis

  NCT03639779

  TerminatedInterventionalPhase 4Updated Jul 1, 2021
• The Early Administration of Sodium Thiosulfate Should Help to Reduce the Mortality of Dialysis Patients With Calciphylaxis, From a National Cohort

  NCT03146793

  Unknown statusObservationalUpdated May 10, 2017

ClinicalTrials.gov ID

NCT03979378

Lead Sponsor

University Hospital, LimogesOTHER

Overall Status

Unknown status

Study Type

Observational

Enrollment

120Estimated

Last Update Posted

Jun 11, 2019Actual

Start Date

Feb 2015Actual

Primary Completion Date

Feb 2020Estimated

Completion Date

Feb 2020Estimated

Official Title

Treatment of Ectopic Calcification / Ossification With Sodium Thiosulfate (CATSSO)

Brief Summary

Ectopic calcification and ossification complicate many diseases, which are rare for the most part. These calcifications (or ossifications) are generally classified according to their apparent formation mechanism. Even if very different diseases can be at the origin, these calcifications (or ossifications) have as common points: an unknown physiopathology, a composition of calcium pyrophosphate for the most part and l no curative treatment validated to date.

Indeed, although several reported cases suggest the potential efficacy of different treatments , none of these treatments is currently recognized as effective because of the absence of confirmation data or because of contradictory results.

Sodium thiosulfate (STS) has been used for a long time as an antidote to cyanide poisoning and as a protective agent against cytotoxic side effects such as ifosphamide. More recently, STS has been reported in the treatment of renal calcification. vascular or even subcutaneous. First prospective studies on animal models and in humans seem to confirm the interest of this product in the treatment of these abnormal calcifications.

For several months, a magistral preparation in the form of ointment based on STS has been developed by the pharmacy of Limoges University Hospital in order to combine the local effect of STS while avoiding the side effects of an administration of this treatment by systemic way. The first uses of this preparation appear promising and some preliminary results have already been published. The benefit / risk ratio of this approach seems to be advantageous for clinicians since preparations whose composition is close are currently validated by the FDA and the World Health Organisation for the treatment of benign pathologies such as cutaneous dermatophytes or pityriasis versicolor.

• Sodium Thiosulfate
• Ectopic Ossification

Ages Eligible for Study

Child (0-17)Adult (18-64)Older Adult (65+)

Sexes Eligible for Study

All

Accepts Healthy Volunteers

No

Eligibility Criteria

Inclusion Criteria:

• any patient treated with sodium thiosulfate dermally provided by the pharmacy of Limoges University Hospital.
• availability of an objective imaging evaluation to compare the volume or surface of calcifications (or ossifications) treated (on two orthogonal incidences) before and after 6 months of treatment application.
• consent to participation in the study signed by the patient or by one of the holders of parental authority in the case of a minor patient.

Exclusion Criteria:

• calcification with concomitant cutaneous rupture which can allow an externalization of the calcium material by mechanical effects.
• Patient with calcification secondary to one of the following pathologies:
• diabetes
• chronic renal failure
• iatrogenic origin

Observational Model

Cohort

Time Perspective

Retrospective

Lead Sponsor

University Hospital, LimogesOTHER

vincent.guigoni@unilim.fr

marie.courbebaisse@aphp.fr

christine.bodemer@aphp.fr